Mostrando 7 resultados de: 7
Filtros aplicados
Subtipo de publicación
Article(7)
Publisher
Bioorganic and Medicinal Chemistry Letters(2)
British Journal of Pharmacology(1)
Chemical and Pharmaceutical Bulletin(1)
Farmaco(1)
Journal of Medicinal Chemistry(1)
Área de conocimiento
Bioquímica(6)
Farmacología(3)
Péptido(3)
Descubrimiento de fármacos(2)
Ciencia de materiales(1)
Origen
google(3)
2,5-Diketopiperidine derivatives as non-peptide ligands for cholecystokinin receptors
ArticleAbstract: Easily accessible 2,5-diketopiperidines have been used as templates for the construction of Trp-PhePalabras claves:Autores:Del Río J., Dominguez M.J., Fortuno A., Garcı́a-López M.T., Gonzalez-Muniz R., Herranz R., Santiago J. BallazFuentes:googlescopus2-Oxopyrrolidines and 6-oxoperhydropyrrolo[1,2-a]pyrazines as templates in the search for nonpeptide cholecystokinin ligands
ArticleAbstract: In order to find new classes of non-peptide cholecystokinin (CCK) ligands, the conformational restriPalabras claves:2-Oxopyrrolidine, Cholecystokinin mimetic, Perhydropyrrolo[1,2-a]pyrazineAutores:Cenarruzabeitia E., Del Río J., Garcı́a-López M.T., Gonzalez-Muniz R., Herranz R., LaTorre M., Martín-Martínez M., Santiago J. BallazFuentes:googlescopus5-(Tryptophyl)amino-1,3-dioxoperhydropyrido[1,2-c]pyrimidine-based potent and selective CCK<inf>1</inf> receptor antagonists: Structural modifications at the tryptophan domain
ArticleAbstract: Analogues of the previously reported potent and highly selective CCK1 receptor antagonist (4aS,5R)-2Palabras claves:Autores:Bartolomé-Nebreda J.M., Cenarruzabeitia E., Del Río J., Garcı́a-López M.T., Gómez-Monterrey I., Gonzalez-Muniz R., Herranz R., LaTorre M., Martín-Martínez M., Santiago J. BallazFuentes:scopusCCK-4 restricted analogues containing a 3-oxoindolizidine skeleton
ArticleAbstract: A series of CCK-4 restricted analogues, incorporating a 3-oxoindolizidine bicyclic lactam as conformPalabras claves:Autores:Barber A., Del Río J., Dominguez M.J., Garcı́a-López M.T., Gonzalez-Muniz R., Herranz R., Martín-Martínez M., Santiago J. BallazFuentes:googlescopusPharmacological evaluation of IQM-95,333, a highly selective CCK(A) receptor antagonist with anxiolytic-like activity in animal models
ArticleAbstract: 1. The pyridopyrimidine derivative IQM-95,333 ((4aS,5R)-2-benzyl-5-[N(α)-tert-butoxicarbonyl)L-tryptPalabras claves:Amylase release, Anxiolytic drugs, CCK(A) receptors, CCK(B) receptors, Cholecystokinin (CCK), Food intakeAutores:Barber A., Del Río J., Fortuno A., Garcı́a-López M.T., Gómez-Monterrey I., Gonzalez-Muniz R., Herranz R., Martín-Martínez M., Santiago J. BallazFuentes:scopusPseudopeptide CCK-4 analogues incorporating the Ψ[CH(CN)NH] peptide bond surrogate
ArticleAbstract: The synthesis, binding to CCK receptors, and in vitro functional activity of pseudopeptide CCK-4 anaPalabras claves:Autores:Barber A., Del Río J., Fortuno A., Garcı́a-López M.T., Gonzalez-Muniz R., Herranz R., Herrero S., Santiago J. Ballaz, Suárez-Gea M.L.Fuentes:scopusSynthesis of chiral 1,6,8-trioxoperhydropyrazino[1,2-c]pyrimidines as novel highly functionalized scaffolds for peptidomimetics
ArticleAbstract: The synthesis of novel chiral 4,7-disubstituted- and 2,4,7-trisubstituted-1,6,8-trioxoperhydropyraziPalabras claves:1,6,8-trioxoperhydropyrazino[1,2-c]pyrimidines, 3,5-disubstituted-2-oxopiperazines, Lactams, Nitrogen bridged bicyclic heterocycles, Peptidomimetics, Urea derivatives, Ψ[CH(CN)NH] pseudodipeptidesAutores:Antonio Salgado, Garcı́a-López M.T., Herranz R., Herrero S.Fuentes:scopus